|
1
|
Molina JR, Yang P, Cassivi SD, Schild SE
and Adjei AA: Non-small cell lung cancer: Epidemiology, risk
factors, treatment, and survivorship. Mayo Clin Proc. 83:584–594.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gajewski TF, Schreiber H and Fu YX: Innate
and adaptive immune cells in the tumor microenvironment. Nat
Immunol. 14:1014–1022. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hirsch FR, Scagliotti GV, Mulshine JL,
Kwon R, Curran WJ Jr, Wu YL and Paz-Ares L: Lung cancer: Current
therapies and new targeted treatments. Lancet. 389:299–311. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stankovic B, Bjørhovde HAK, Skarshaug R,
Aamodt H, Frafjord A, Müller E, Hammarström C, Beraki K, Bækkevold
ES, Woldbæk PR, et al: Immune Cell Composition in Human Non-small
Cell Lung Cancer. Front Immunol. 9:31012019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu X, Wu S, Yang Y, Zhao M, Zhu G and Hou
Z: The prognostic landscape of tumor-infiltrating immune cell and
immunomodulators in lung cancer. Biomed Pharmacother. 95:55–61.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Poh AR and Ernst M: Targeting macrophages
in cancer: From bench to bedside. Front Oncol. 8:492018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Loyher PL, Hamon P, Laviron M,
Meghraoui-Kheddar A, Goncalves E, Deng Z, Torstensson S, Bercovici
N, Baudesson de Chanville C, Combadière B, et al: Macrophages of
distinct origins contribute to tumor development in the lung. J Exp
Med. 215:2536–2553. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bolkun L, Grubczak K, Schneider G, Zembko
P, Radzikowska U, Singh P, Kloczko J, Ratajczak MZ, Moniuszko M and
Eljaszewicz A: Involvement of BAFF and APRIL in Resistance to
Apoptosis of Acute Myeloid Leukemia. J Cancer. 7:1979–1983. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bolkun L, Lemancewicz D, Jablonska E,
Szumowska A, Bolkun-Skornicka U, Ratajczak-Wrona W, Dzieciol J and
Kloczko J: The impact of TNF superfamily molecules on overall
survival in acute myeloid leukaemia: Correlation with biological
and clinical features. Ann Hematol. 94:35–43. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Meinl E, Thaler FS and Lichtenthaler SF:
Shedding of BAFF/APRIL receptors controls B cells. Trends Immunol.
39:673–676. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kern C, Cornuel JF, Billard C, Tang R,
Rouillard D, Stenou V, Defrance T, Ajchenbaum-Cymbalista F, Simonin
PY, Feldblum S, et al: Involvement of BAFF and APRIL in the
resistance to apoptosis of B-CLL through an autocrine pathway.
Blood. 103:679–688. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pelekanou V, Notas G, Athanasouli P,
Alexakis K, Kiagiadaki F, Peroulis N, Kalyvianaki K, Kampouri E,
Polioudaki H, Theodoropoulos P, et al: BCMA (TNFRSF17) induces
APRIL and BAFF mediated breast cancer cell stemness. Front Oncol.
8:3012018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moreaux J, Veyrune JL, De Vos J and Klein
B: APRIL is overexpressed in cancer: Link with tumor progression.
BMC Cancer. 9:832009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Quinn J, Glassford J, Percy L, Munson P,
Marafioti T, Rodriguez-Justo M and Yong K: APRIL promotes
cell-cycle progression in primary multiple myeloma cells: Influence
of D-type cyclin group and translocation status. Blood.
117:890–901. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bolkun L, Lemancewicz D, Jablonska E,
Kulczynska A, Bolkun-Skornicka U, Kloczko J and Dzieciol J: BAFF
and APRIL as TNF superfamily molecules and angiogenesis parallel
progression of human multiple myeloma. Ann Hematol. 93:635–644.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang S, Li JY and Xu W: Role of
BAFF/BAFF-R axis in B-cell non-Hodgkin lymphoma. Crit Rev Oncol
Hematol. 91:113–122. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tai YT, Acharya C, An G, Moschetta M,
Zhong MY, Feng X, Cea M, Cagnetta A, Wen K, van Eenennaam H, et al:
APRIL and BCMA promote human multiple myeloma growth and
immunosuppression in the bone marrow microenvironment. Blood.
127:3225–3236. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Koizumi M, Hiasa Y, Kumagi T, Yamanishi H,
Azemoto N, Kobata T, Matsuura B, Abe M and Onji M: Increased B
cell-activating factor promotes tumor invasion and metastasis in
human pancreatic cancer. PLoS One. 8:e713672013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kampa M, Notas G, Stathopoulos EN, Tsapis
A and Castanas E: The TNFSF members APRIL and BAFF and their
receptors TACI, BCMA, and BAFFR in oncology, with a special focus
in breast cancer. Front Oncol. 10:8272020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Novak AJ, Grote DM, Stenson M, Ziesmer SC,
Witzig TE, Habermann TM, Harder B, Ristow KM, Bram RJ, Jelinek DF,
et al: Expression of BLyS and its receptors in B-cell non-Hodgkin
lymphoma: Correlation with disease activity and patient outcome.
Blood. 104:2247–2253. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Notas G, Alexaki VI, Kampa M, Pelekanou V,
Charalampopoulos I, Sabour-Alaoui S, Pediaditakis I, Dessirier V,
Gravanis A, Stathopoulos EN, et al: APRIL binding to BCMA activates
a JNK2-FOXO3-GADD45 pathway and induces a G2/M cell growth arrest
in liver cells. J Immunol. 189:4748–4758. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dou H, Yan Z, Zhang M and Xu X: APRIL,
BCMA and TACI proteins are abnormally expressed in non-small cell
lung cancer. Oncol Lett. 12:3351–3355. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dou H, Yan Z, Zhang M and Xu X: APRIL
promotes non-small cell lung cancer growth and metastasis by
targeting ERK1/2 signaling. Oncotarget. 8:109289–109300. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qian Z, Qingshan C, Chun J, Huijun Z, Feng
L, Qiang W, Qiang X and Min Z: High expression of TNFSF13 in tumor
cells and fibroblasts is associated with poor prognosis in
non-small cell lung cancer. Am J Clin Pathol. 141:226–233. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hao Y, Triadafilopoulos G, Sahbaie P,
Young HS, Omary MB and Lowe AW: Gene expression profiling reveals
stromal genes expressed in common between Barrett's esophagus and
adenocarcinoma. Gastroenterology. 131:925–933. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lee C, Park JW, Suh JH and Moon KC: High
expression of APRIL correlates with poor prognosis in clear cell
renal cell carcinoma. Pathol Res Pract. 211:824–828. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Korkola JE, Houldsworth J, Chadalavada RS,
Olshen AB, Dobrzynski D, Reuter VE, Bosl GJ and Chaganti RS:
Down-regulation of stem cell genes, including those in a 200-kb
gene cluster at 12p13.31, is associated with in vivo
differentiation of human male germ cell tumors. Cancer Res.
66:820–827. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sanchez-Carbayo M, Socci ND, Lozano J,
Saint F and Cordon-Cardo C: Defining molecular profiles of poor
outcome in patients with invasive bladder cancer using
oligonucleotide microarrays. J Clin Oncol. 24:778–789. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sun B, Wang H, Wang X, Huang H, Ding W,
Jing R, Shi G and Zhu L: A proliferation-inducing ligand: A new
biomarker for non-small cell lung cancer. Exp Lung Res. 35:486–500.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sahai E, Astsaturov I, Cukierman E,
DeNardo DG, Egeblad M, Evans RM, Fearon D, Greten FR, Hingorani SR,
Hunter T, et al: A framework for advancing our understanding of
cancer-associated fibroblasts. Nat Rev Cancer. 20:174–186. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen X and Song E: Turning foes to
friends: Targeting cancer-associated fibroblasts. Nat Rev Drug
Discov. 18:99–115. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chen J, He D, Chen Q, Guo X, Yang L, Lin
X, Li Y, Wu W, Yang Y, He J, et al: BAFF is involved in
macrophage-induced bortezomib resistance in myeloma. Cell Death
Dis. 8:e31612017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Manfroi B, McKee T, Mayol JF, Tabruyn S,
Moret S, Villiers C, Righini C, Dyer M, Callanan M, Schneider P, et
al: CXCL-8/IL8 produced by diffuse large B-cell lymphomas recruits
neutrophils expressing a proliferation-inducing ligand APRIL.
Cancer Res. 77:1097–1107. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lowin T, Anssar TM, Bäuml M, Classen T,
Schneider M and Pongratz G: Positive and negative cooperativity of
TNF and Interferon-γ in regulating synovial fibroblast function and
B cell survival in fibroblast/B cell co-cultures. Sci Rep.
10:7802020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mackay F and Tangye SG: The role of the
BAFF/APRIL system in B cell homeostasis and lymphoid cancers. Curr
Opin Pharmacol. 4:347–354. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
He B, Chadburn A, Jou E, Schattner EJ,
Knowles DM and Cerutti A: Lymphoma B cells evade apoptosis through
the TNF family members BAFF/BLyS and APRIL. J Immunol.
172:3268–3279. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ni SZ, Cao HY, Chen Z, Zhu Y and Xu ZK:
siRNA interference with a proliferation-inducing ligand gene in the
Sgr-7901 gastric carcinoma cell line. Asian Pac J Cancer Prev.
13:1511–1514. 2012. View Article : Google Scholar : PubMed/NCBI
|
